Assembly of the Escherichia coli RuvABC resolvasome directs the orientation of Holliday junction resolution

  1. Alain J. van Gool,
  2. Nasser M.A. Hajibagheri,
  3. Andrzej Stasiak, and
  4. Stephen C. West
  1. Genetic Recombination Laboratory, Imperial Cancer Research Fund (ICRF) South Mimms, Herts EN6 3LD, UK; Electron Microscopy Unit, Imperial Cancer Research Fund, London WC2A 3PX, UK; Laboratoire d’Analyse Ultrastructurale, Universitéde Lausanne, Lausanne, Switzerland

Abstract

Genetic recombination can lead to the formation of intermediates in which DNA molecules are linked by Holliday junctions. Movement of a junction along DNA, by a process known as branch migration, leads to heteroduplex formation, whereas resolution of a junction completes the recombination process. Holliday junctions can be resolved in either of two ways, yielding products in which there has, or has not, been an exchange of flanking markers. The ratio of these products is thought to be determined by the frequency with which the two isomeric forms (conformers) of the Holliday junction are cleaved. Recent studies with enzymes that process Holliday junctions in Escherichia coli, the RuvABC proteins, however, indicate that protein binding causes the junction to adopt an open square-planar configuration. Within such a structure, DNA isomerization can have little role in determining the orientation of resolution. To determine the role that junction-specific protein assembly has in determining resolution bias, a defined in vitro system was developed in which we were able to direct the assembly of the RuvABC resolvasome. We found that the bias toward resolution in one orientation or the other was determined simply by the way in which the Ruv proteins were positioned on the junction. Additionally, we provide evidence that supports current models on RuvABC action in which Holliday junction resolution occurs as the resolvasome promotes branch migration.

Keywords

Footnotes

  • Present address: N.V. Organon, 5340 BH Oss, The Netherlands.

  • Corresponding author.

  • E-MAIL s.west{at}icrf.icnet.uk; FAX (44)-(0)-171-269-3811.

    • Received April 27, 1999.
    • Accepted June 1, 1999.
| Table of Contents

Life Science Alliance